Show Cart

More News

15 Jul 2018 MolMed signs a new, three-year agreement for the development and supply of lentiviral vectors
13 Jul 2018 4D Molecular Therapeutics and MedImmune Collaborate to Design, Develop and Commercialize AAV Gene Therapy for Chronic Lung Disease
13 Jul 2018 Arcus Biosciences Announces That Taiho Pharmaceutical Has Exercised Its Option to Develop and Commercialize AB928 in Its Territories
13 Jul 2018 Cue Biopharma Produces Immuno-STAT™ Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
12 Jul 2018 Roivant subsidiary Dermavant Sciences signs agreement with GSK to purchase rights to tapinarof
12 Jul 2018 Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-Generation Antibody-Based Therapeutics into the Clinic
12 Jul 2018 Immatics Enters into a Strategic Partnership with Genmab to Develop Next Generation Bispecific Cancer Immunotherapies
11 Jul 2018 Otsuka Pharmaceutical to Acquire Visterra
11 Jul 2018 Idera Pharmaceuticals Announces Termination of Merger Agreement with BioCryst Pharmaceuticals
10 Jul 2018 BioNTech and Genevant Sciences Sign Strategic mRNA-Focused Partnership in Rare Diseases
10 Jul 2018 Adlai Nortye Announce Global License Agreement for Buparlisib (BKM120)
10 Jul 2018 NIH and Matinas BioPharma Announce Research Collaboration to Identify Novel HIV Therapy Utilizing LNC Platform Delivery Technology
10 Jul 2018 MabVax Therapeutics and Boehringer Ingelheim Sign Asset Purchase and License Agreement and Related Agreements for an Antibody Development Program Targeting Multiple Solid Tumor Cancers
10 Jul 2018 Axovant Announces Global Licensing Agreement for AXO-AAV-OPMD Program for Treatment of Oculopharyngeal Muscular Dystrophy and Broader Platform Collaboration with Benitec Biopharma
03 Jul 2018 TRIGR Therapeutics and ABL Bio Announce Global Oncology Collaboration on Pipeline of Next Generation Therapeutic Antibodies
01 Jul 2018 Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases
29 Jun 2018 APEIRON, the Medical University of Vienna and the Institute of Molecular Biotechnology Sign Licensing Agreement for a New Checkpoint Inhibitor
29 Jun 2018 Novartis announces intention to seek shareholder approval for 100% spinoff of Alcon eye care devices business; initiates share buyback of up to USD 5 bn
29 Jun 2018 Biogen Exercises Option to Increase Ownership in Samsung Bioepis
28 Jun 2018 Devonian Announces the Signing of a Non-Binding Letter of Intent with Folia Biotech to develop FB-631 in cancer immunotherapy
28 Jun 2018 MolMed and AbCheck sign a three-year Master Agreement for the development of new CARs targeting novel tumor antigens
28 Jun 2018 Akebia Therapeutics and Keryx Biopharmaceuticals to Merge, Creating a Fully Integrated Company Focused on the Development and Commercialization of Therapeutics for Patients with Kidney Disease
28 Jun 2018 NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S
28 Jun 2018 Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar
27 Jun 2018 GC LabCell and Feldan Therapeutics announce license agreement to develop next-generation NK cells for immunotherapy using Feldan Shuttle technology

Currencies

Shopping cart

Cart empty

Latest report

Featured Products

Latest Target Pipeline

Currencies

Shopping cart

Cart empty

Latest report

Featured Products

Latest Target Pipeline

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top